A. Glässer

776 total citations
54 papers, 559 citations indexed

About

A. Glässer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, A. Glässer has authored 54 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Physiology. Recurrent topics in A. Glässer's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Chemical synthesis and alkaloids (6 papers). A. Glässer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Chemical synthesis and alkaloids (6 papers). A. Glässer collaborates with scholars based in Italy, Czechia and Albania. A. Glässer's co-authors include C. Beretta, V. Erspamer, L. Dorigotti, G.B. Fregnan, Franco Luzzani, Domenico Barone, A.E. Restelli, Giulio Galliani, Romano Silvestri and E Turolla and has published in prestigious journals such as Nature, Circulation Research and British Journal of Pharmacology.

In The Last Decade

A. Glässer

51 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Glässer Italy 14 188 174 84 77 61 54 559
W. Lippmann United States 16 222 1.2× 204 1.2× 77 0.9× 86 1.1× 178 2.9× 71 719
John M. Stavorski United States 11 219 1.2× 200 1.1× 132 1.6× 65 0.8× 60 1.0× 16 593
Morton E. Goldberg United States 9 218 1.2× 140 0.8× 51 0.6× 38 0.5× 82 1.3× 15 584
William Paton United Kingdom 10 458 2.4× 277 1.6× 114 1.4× 39 0.5× 113 1.9× 23 873
Herbert C. Wenger United States 10 263 1.4× 225 1.3× 130 1.5× 47 0.6× 42 0.7× 18 659
Joseph J. McPhillips United States 15 219 1.2× 164 0.9× 117 1.4× 36 0.5× 101 1.7× 25 613
Carl T. Ludden United States 12 306 1.6× 212 1.2× 144 1.7× 60 0.8× 66 1.1× 25 766
C. C. Toh Singapore 9 127 0.7× 146 0.8× 124 1.5× 29 0.4× 54 0.9× 16 553
T. L. B. Spriggs United Kingdom 16 278 1.5× 274 1.6× 192 2.3× 25 0.3× 80 1.3× 34 802
S. R. Nahorski United Kingdom 15 379 2.0× 300 1.7× 106 1.3× 42 0.5× 43 0.7× 38 719

Countries citing papers authored by A. Glässer

Since Specialization
Citations

This map shows the geographic impact of A. Glässer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Glässer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Glässer more than expected).

Fields of papers citing papers by A. Glässer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Glässer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Glässer. The network helps show where A. Glässer may publish in the future.

Co-authorship network of co-authors of A. Glässer

This figure shows the co-authorship network connecting the top 25 collaborators of A. Glässer. A scholar is included among the top collaborators of A. Glässer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Glässer. A. Glässer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Francesco, G. F. Di, et al.. (1986). Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs.. PubMed. 36(1). 84–8. 1 indexed citations
2.
Luzzani, Franco, et al.. (1984). Inhibition of PG production by MDL 035, a new non-steroidal non-acidic anti-inflammatory compound, in rat gastric mucosa and inflammatory exudate. Pharmacological Research Communications. 16(8). 755–763. 3 indexed citations
3.
Luzzani, Franco, et al.. (1984). Ex vivo binding to thymic glucocorticoid receptors: correlation with biological responses.. PubMed. 171. 313–20. 1 indexed citations
4.
Restelli, A.E., et al.. (1984). Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat. Pharmacological Research Communications. 16(2). 117–127. 3 indexed citations
5.
Coruzzi, Gabriella, E. Poli, Maristella Adami, G. Bertaccini, & A. Glässer. (1983). Effect of MDL 646, a new synthetic prostaglandin, on gastroesophageal motility of the rat.. PubMed. 38(2). 121–7. 2 indexed citations
6.
Barone, Domenico, et al.. (1982). Biochemical and pharmacological activities of zetidoline (DL 308-IT): a new antidopaminergic agent. Journal of Pharmacy and Pharmacology. 34(2). 129–132. 20 indexed citations
7.
Luzzani, Franco & A. Glässer. (1981). Differential binding in vitro to glucocorticoid receptors of deflazacort and prednisolone. European Journal of Pharmacology. 76(4). 427–430. 12 indexed citations
8.
Fregnan, G.B. & A. Glässer. (1969). Reduction of Antineoplastic Drug Intoxication by 5-Hydroxytryptamine Antagonists. Pharmacology. 2(4). 217–222. 1 indexed citations
9.
Dorigotti, L., M. Gaetani, A. Glässer, & E Turolla. (1969). Competitive antagonism of isoprenaline-induced cardiac necroses by β-adrenoreceptor blocking agents. Journal of Pharmacy and Pharmacology. 21(3). 188–191. 9 indexed citations
10.
Fregnan, G.B. & A. Glässer. (1968). Structure-activity relationship of various acyl derivatives of 6-methyl-8β-aminomethyl-10α-ergoline (dihydrolysergamine). Cellular and Molecular Life Sciences. 24(2). 150–151. 5 indexed citations
11.
Glässer, A., et al.. (1968). Restraint-induced gastric ulcers in the golden hamster. Journal of Pharmacy and Pharmacology. 20(1). 73–73. 4 indexed citations
12.
Bernardi, Luigi Rossi, Roberto Castiglione, G.B. Fregnan, & A. Glässer. (1967). An experimental approach to long-lasting hypotensive eledoisin-like peptides. Journal of Pharmacy and Pharmacology. 19(2). 95–101. 6 indexed citations
13.
Fregnan, G.B. & A. Glässer. (1965). Synergistic Action of an Anti-5-Hydroxytryptamine, Anti-Histamines and Cortisone in Experimental Anaphylaxis. Pharmacology. 13(3). 189–198. 1 indexed citations
14.
Beretta, C., et al.. (1965). 1-Methyl-8 β-carbobenzyloxy-aminomethyl-10 α-ergoline, a Potent and Long-lasting 5-Hydroxytryptamine Antagonist. Nature. 207(4995). 421–422. 90 indexed citations
15.
Glässer, A., et al.. (1963). Action of Guanethidine on the 5-Hydroxytryptamine Content of the Brain. Journal of Pharmacy and Pharmacology. 15(1). 772–773. 3 indexed citations
16.
Glässer, A.. (1961). Some Pharmacological Actions of D-Lysergic Acid Methyl Carbinolamide. Nature. 189(4761). 313–314. 2 indexed citations
17.
18.
Glässer, A., et al.. (1960). Action de laDl-3-4-dioxyphenillalanine (DOPA) et de la dopamine sur l'activitè èlectrique du chat "cerveau isolè". ARCHIVES ITALIENNES DE BIOLOGIE. 98(4). 367–374. 10 indexed citations
19.
Erspamer, V., et al.. (1960). A Note on the Oxidative Deamination of Isomers of 5-Hydroxytryptamine and Other Indolealkylamines. Journal of Pharmacy and Pharmacology. 12(1). 761–764. 6 indexed citations
20.
Erspamer, V. & A. Glässer. (1957). THE PHARMACOLOGICAL ACTIONS OF MUREXINE (UROCANYLCHOLINE). British Journal of Pharmacology and Chemotherapy. 12(2). 176–184. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Lippmann Breakdown of academic impact, for papers by John M. Stavorski Breakdown of academic impact, for papers by Morton E. Goldberg Breakdown of academic impact, for papers by William Paton Breakdown of academic impact, for papers by Herbert C. Wenger Breakdown of academic impact, for papers by Joseph J. McPhillips Breakdown of academic impact, for papers by Carl T. Ludden Breakdown of academic impact, for papers by C. C. Toh Breakdown of academic impact, for papers by T. L. B. Spriggs Breakdown of academic impact, for papers by S. R. Nahorski
Rankless by CCL
2026